BIOX Stock — Price, Charts & Analysis

Bioceres Crop Solutions Corp. (BIOX) has no trailing P/E shown and a forward P/E of 0.70x. This places BIOX in a lower earnings multiple territory based on the valuation data currently available on Worldtickers.

BIOX trades with 0.70x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether BIOX looks overvalued or undervalued.

BIOX's P/E of 0.70x should be judged against Basic Materials peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

BIOX's trailing EPS is -$1.06 and forward EPS is $0.64.

EPS, or earnings per share, shows how much profit Bioceres Crop Solutions Corp. generated for each share. BIOX's trailing EPS is -$1.06, and investors usually prefer EPS that is positive and growing over time.

Bioceres Crop Solutions Corp. has a market cap of $28.71M, making BIOX a small-cap stock based on the current market value shown on Worldtickers.

BIOX's latest stock price on Worldtickers is $0.45. The latest move is $0.04 or 8.49%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

BIOX's quote includes a latest price of $0.45. The market open is $0.41. Previous close is $0.41. The intraday range is $0.40 to $0.45.

BIOX is up in the latest quote, with a move of $0.04 or 8.49%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

BIOX generated $255.21M in trailing revenue. Revenue growth is -35.90%, which helps show whether demand is expanding or slowing.

BIOX's revenue growth is -35.90%, which is a negative demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, BIOX does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$66.55M.

Gross margin is 36.60%. Margins show how efficiently Bioceres Crop Solutions Corp. turns revenue into profit.

Bioceres Crop Solutions Corp. carries $239.00M and holds $14.90M in cash.

BIOX holds $14.90M on its balance sheet.

BIOX's book value per share is $1.06.

Institutions hold 23.13% of BIOX shares. Insiders hold 16.95% of shares. Ownership mix helps investors understand how much of Bioceres Crop Solutions Corp. is held by professional investors and company insiders.

BIOX has 63.82M shares outstanding. Float shares are 44.33M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for BIOX, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for BIOX is $0.64. Revenue growth is -35.90%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

BIOX's trailing EPS is -$1.06. Forward EPS is $0.64. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

BIOX is in the Basic Materials sector. Its earnings multiple is 0.70x. Its latest displayed growth metric is -35.90%. Compare these figures with sector peers before deciding whether Bioceres Crop Solutions Corp. is stronger or weaker than average.

BIOX trades at $0.45. The stock trades at 0.70x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Bioceres Crop Solutions Corp.'s fundamentals.

BIOX risks include company execution, valuation, competition in Basic Materials, interest rates, and broad market volatility. No single stock should be evaluated without portfolio context.

BIOX should be compared with companies in Agricultural Inputs. Its earnings multiple is 0.70x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Bioceres Crop Solutions Corp. (BIOX) operates in Basic Materials, specifically Agricultural Inputs. Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition se

BIOX trades on NasdaqGS. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

BIOX stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Bioceres Crop Solutions Corp.'s official website listed on Worldtickers is investors.biocerescrops.com/home/default.aspx. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Bioceres Crop Solutions Corp. employs about 751 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Bioceres Crop Solutions Corp. is headquartered in Rosario, Argentina. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

BIOX is in the Basic Materials sector and the Agricultural Inputs industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

BIOX has traded between $0.30 and $3.07 over the past 52 weeks. At $0.45, it is 85.34% below the high and 49.47% above the low. The 52-week range helps gauge long-term price momentum.

BIOX is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is $0.37 and its 200-day moving average is $0.77.

BIOX's RSI is 66.60. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

BIOX's latest RSI reading is 66.60, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for BIOX is near $0.30. Key resistance is near $0.47. Breaks above resistance or below support can change the short-term technical setup.

BIOX's nearest reported support level is $0.30. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

BIOX's nearest reported resistance level is $0.47. A breakout above resistance can improve momentum, especially when volume confirms the move.

BIOX trades about 207.13K shares daily on average. The latest displayed volume is 123.57K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

BIOX's MACD is 0.01, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

BIOX is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 66.60 (neutral). MACD is bullish. Nearest support is around $0.30. Resistance is around $0.47. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $0.38 (19.78% from price). MA50 is $0.37 (22.21% from price). MA200 is $0.77 (-41.73% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. BIOX's MA20 is $0.38. MA50 is $0.37. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

BIOX's pivot is near $0.41. Support is near $0.30. Resistance is near $0.47. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for BIOX is near $0.42. The next upper resistance zone is near $0.53. These levels help define risk and possible follow-through zones after a breakout or breakdown.

BIOX's Bollinger range is roughly $0.29 to $0.46. Band width is near 43.96%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

BIOX's ATR-based typical daily range is about 8.70%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 123.57K shares. Average volume is about 207.13K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

BIOX's all-time high shown on Worldtickers is $17.94. Its all-time low is $0.30. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.